US Bancorp’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$104K Sell
5,823
-152
-3% -$2.71K ﹤0.01% 2401
2025
Q1
$106K Sell
5,975
-126
-2% -$2.25K ﹤0.01% 2365
2024
Q4
$182K Buy
6,101
+344
+6% +$10.3K ﹤0.01% 2068
2024
Q3
$90K Sell
5,757
-1,246
-18% -$19.5K ﹤0.01% 2443
2024
Q2
$120K Buy
7,003
+2,466
+54% +$42.2K ﹤0.01% 2250
2024
Q1
$70.9K Buy
4,537
+800
+21% +$12.5K ﹤0.01% 2522
2023
Q4
$55.8K Buy
3,737
+1,179
+46% +$17.6K ﹤0.01% 2616
2023
Q3
$41.3K Buy
2,558
+1,176
+85% +$19K ﹤0.01% 2539
2023
Q2
$57.4K Sell
1,382
-123
-8% -$5.11K ﹤0.01% 2418
2023
Q1
$90.5K Buy
1,505
+139
+10% +$8.36K ﹤0.01% 2237
2022
Q4
$100K Sell
1,366
-1,218
-47% -$89.3K ﹤0.01% 2185
2022
Q3
$197K Sell
2,584
-70
-3% -$5.34K ﹤0.01% 1857
2022
Q2
$185K Sell
2,654
-203
-7% -$14.2K ﹤0.01% 1917
2022
Q1
$237K Buy
2,857
+454
+19% +$37.7K ﹤0.01% 1873
2021
Q4
$180K Buy
2,403
+166
+7% +$12.4K ﹤0.01% 2015
2021
Q3
$260K Sell
2,237
-1,071
-32% -$124K ﹤0.01% 1844
2021
Q2
$734K Buy
3,308
+430
+15% +$95.4K ﹤0.01% 1362
2021
Q1
$381K Buy
2,878
+122
+4% +$16.2K ﹤0.01% 1627
2020
Q4
$476K Sell
2,756
-6,496
-70% -$1.12M ﹤0.01% 1461
2020
Q3
$1.03M Sell
9,252
-14
-0.2% -$1.56K ﹤0.01% 978
2020
Q2
$549K Sell
9,266
-1,008
-10% -$59.7K ﹤0.01% 1236
2020
Q1
$692K Sell
10,274
-337
-3% -$22.7K ﹤0.01% 1046
2019
Q4
$894K Sell
10,611
-300
-3% -$25.3K ﹤0.01% 1099
2019
Q3
$816K Sell
10,911
-2,089
-16% -$156K ﹤0.01% 1130
2019
Q2
$822K Sell
13,000
-500
-4% -$31.6K ﹤0.01% 1160
2019
Q1
$650K Hold
13,500
﹤0.01% 1263
2018
Q4
$452K Buy
13,500
+500
+4% +$16.7K ﹤0.01% 1385
2018
Q3
$681K Hold
13,000
﹤0.01% 1306
2018
Q2
$407K Hold
13,000
﹤0.01% 1532
2018
Q1
$283K Hold
13,000
﹤0.01% 1691
2017
Q4
$263K Hold
13,000
﹤0.01% 1732
2017
Q3
$258K Buy
13,000
+3,000
+30% +$59.5K ﹤0.01% 1739
2017
Q2
$173K Hold
10,000
﹤0.01% 1916
2017
Q1
$81K Hold
10,000
﹤0.01% 2248
2016
Q4
$79K Buy
+10,000
New +$79K ﹤0.01% 2217